Talk:Ivabradine

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Start‑class Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Start	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ivabradine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

HF-REF

Review of role in heart failure care doi:10.1161/CIRCULATIONAHA.115.018094 JFW | T@lk 10:53, 24 May 2016 (UTC)[reply]

Ivabradine as potential relief for Oxaliplatin induced peripheral Neuropathy

Ivabradine has been linked to the possible remediation of Peripheral Neuropathy induced by Oxilaplatin Chemotherapy treatment

This article refers https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377073/ — Preceding unsigned comment added by Jrgbrowne (talk • contribs) 13:24, 3 April 2018 (UTC)[reply]

Nonbreaking hyphens appear as glyphs in Chrome

I fixed a subtle typographical issue on this page. The compound adjective "long-term" used a breaking hyphen which, when I accessed the page in Chrome in incognito mode, appeared as a broken glyph. This is a bug in Chrome since at least version 96 and not yet fixed as of 10 Jan 2023 per crbug.com/1267606. The diff would appear like my change did nothing, but in fact I changed the underlying character encoding from U+2011 to U+002D (the default for the dash or hyphen on a MacBook us-en keyboard), thus resolving the broken glyph. While we generally would use the template {{nbh}} in this situation i.e., long{{nbh}}term, to explicitly indicate the intended punctuation, I'm not sure it would remedy the situation as the rendering issue is specific to Chrome. So, we could keep the nonbreaking hyphen as-is and let the Chrome devs fix the rendering issue since it's a browser-specific bug, or we could use a plain dash that eliminates the issue entirely and is consistent with wp:nbhyphen. ― Aidan ⦿ (talk) 00:52, 11 January 2023 (UTC)[reply]

Verapamil

This molecule looks like a cousin of verapamil! --FK1954 (talk) 12:22, 9 August 2023 (UTC)[reply]